Parkman Healthcare Partners LLC Precigen, Inc. Transaction History
Parkman Healthcare Partners LLC
- $746 Million
- Q2 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 1,542,823 shares of PGEN stock, worth $6.42 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
1,542,823
Previous 3,191,343
51.66%
Holding current value
$6.42 Million
Previous $4.76 Million
53.94%
% of portfolio
0.29%
Previous 0.62%
Shares
2 transactions
Others Institutions Holding PGEN
# of Institutions
165Shares Held
166MCall Options Held
511KPut Options Held
1M-
Third Security, LLC83.5MShares$347 Million73.5% of portfolio
-
Patient Capital Management, LLC Baltimore, MD16.3MShares$67.7 Million1.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.3MShares$46.9 Million0.03% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$42.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.07MShares$37.7 Million0.0% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $866M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...